Carlos Quintero, Judith Corona, M. Ponce, A. Aviles, O. Gutiérrez, M. Candelaria
{"title":"Transient monoclonal gammopathy and hypercalcemia in a male patient with Systemic Lupus Erythematosus","authors":"Carlos Quintero, Judith Corona, M. Ponce, A. Aviles, O. Gutiérrez, M. Candelaria","doi":"10.1016/J.LABCLI.2018.07.005","DOIUrl":"https://doi.org/10.1016/J.LABCLI.2018.07.005","url":null,"abstract":"","PeriodicalId":101105,"journal":{"name":"Revista del Laboratorio Clínico","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89341414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
María Pierna Álvarez , Elena Marcos-Vadillo , Belén García-Berrocal , María Isidoro-García
{"title":"Farmacogenómica: la medicina personalizada","authors":"María Pierna Álvarez , Elena Marcos-Vadillo , Belén García-Berrocal , María Isidoro-García","doi":"10.1016/j.labcli.2018.07.004","DOIUrl":"https://doi.org/10.1016/j.labcli.2018.07.004","url":null,"abstract":"<div><p>The main objective of pharmacogenomics (PGx) is defining an individualized pharmacological treatment based on the genetic profile of each patient. Thus, the classical paradigm of clinical treatment focused on the disease is becoming a new approach, Personalized Medicine. The expression and function of enzymes and proteins involved in the drug pharmacokinetics and pharmacodynamics can be modified by genetic polymorphisms. Thereby, the presence of allelic variants allows predicting the pharmacological response guaranteeing the treatment efficacy and safety.</p><p>Nowadays, two different approaches have been described for the clinical application of PGx by these variants identification: candidate gene analysis and genome wide association studies. Despite improving the effectiveness, safety and cost-effectiveness of treatments, the PGx clinical implementation has slowed down due to a series of barriers that will be reviewed in this work, as well as their possible solutions.</p></div>","PeriodicalId":101105,"journal":{"name":"Revista del Laboratorio Clínico","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.labcli.2018.07.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91637097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
S. Zaera, Noa Villar-Mallo, Marta González Vilanova, María Carmen Díaz Lozano, Juan J. Garrido-Sánchez, Lola Máiz Suárez
{"title":"About the correct definition of acanthocytes for their use as markers of glomerular haematuria","authors":"S. Zaera, Noa Villar-Mallo, Marta González Vilanova, María Carmen Díaz Lozano, Juan J. Garrido-Sánchez, Lola Máiz Suárez","doi":"10.1016/J.LABCLI.2019.02.004","DOIUrl":"https://doi.org/10.1016/J.LABCLI.2019.02.004","url":null,"abstract":"","PeriodicalId":101105,"journal":{"name":"Revista del Laboratorio Clínico","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76847085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Álvaro González , Clara Pérez Barrios , Hada Macher , Marta Sánchez-Carbayo , Antonio Barco Sánchez , Antonio Fernández Suárez , Antonio Martínez Peinado , Blanca Ortiz Muñoz , Jaume Trapé Pujol , José Diego Santotoribio Camacho , Josep María Augé Fradera , María Jesús Gaspar Blázquez , Rosa Carbonell Muñoz , Xavier Filella Pla , Comité Científico de la Sociedad Española de Medicina de Laboratorio (SEQCML)
{"title":"Recomendaciones preanalíticas para la obtención y análisis de ADN circulante a partir de sangre periférica. Recomendación (2018)","authors":"Álvaro González , Clara Pérez Barrios , Hada Macher , Marta Sánchez-Carbayo , Antonio Barco Sánchez , Antonio Fernández Suárez , Antonio Martínez Peinado , Blanca Ortiz Muñoz , Jaume Trapé Pujol , José Diego Santotoribio Camacho , Josep María Augé Fradera , María Jesús Gaspar Blázquez , Rosa Carbonell Muñoz , Xavier Filella Pla , Comité Científico de la Sociedad Española de Medicina de Laboratorio (SEQCML)","doi":"10.1016/j.labcli.2018.11.002","DOIUrl":"https://doi.org/10.1016/j.labcli.2018.11.002","url":null,"abstract":"<div><p>Cell-free DNA analysis in peripheral blood has been shown to be useful in oncology, organ transplantation, and prenatal screening. For its introduction into the clinical laboratory, it is necessary to ensure appropriate, reproducible and standardised pre-analytical protocols are in place. The aim of this document is to provide pre-analytical recommendations for obtaining of cell free DNA from peripheral blood. These recommendations include the type of sample and extraction tube, the method of centrifugation, the method for cell free DNA extraction, and measurement and storage conditions.</p></div>","PeriodicalId":101105,"journal":{"name":"Revista del Laboratorio Clínico","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.labcli.2018.11.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91682720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
María Pierna Álvarez, Elena Marcos-Vadillo, Belén García-Berrocal, M. Isidoro-García
{"title":"Farmacogenómica: la medicina personalizada","authors":"María Pierna Álvarez, Elena Marcos-Vadillo, Belén García-Berrocal, M. Isidoro-García","doi":"10.1016/J.LABCLI.2018.07.004","DOIUrl":"https://doi.org/10.1016/J.LABCLI.2018.07.004","url":null,"abstract":"","PeriodicalId":101105,"journal":{"name":"Revista del Laboratorio Clínico","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77941663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Carlos Quintero , Judith Corona , Mayra Ponce , Alejandro Avilés , Olga Gutierrez , Myrna Candelaria
{"title":"Transient monoclonal gammopathy and hypercalcemia in a male patient with Systemic Lupus Erythematosus","authors":"Carlos Quintero , Judith Corona , Mayra Ponce , Alejandro Avilés , Olga Gutierrez , Myrna Candelaria","doi":"10.1016/j.labcli.2018.07.005","DOIUrl":"https://doi.org/10.1016/j.labcli.2018.07.005","url":null,"abstract":"<div><p><span><span><span>Systemic Lupus Erythematosus (SLE) as an autoimmune disorder, is characterized by a profound </span>B cell activation<span>, however, the association of this disease with a monoclonal gammopathy has been infrequently reported, while </span></span>hypercalcemia is associated with Hypercalcemia-Lymphadenopathy Syndrome (HL-SLE). We report the case of a 45-year-old man, with anemia, </span>hypoalbuminemia<span><span>, hypergammaglobulinemia, hypercalcemia, and bone marrow infiltrated with plasma cells. He was diagnosed as Monoclonal Gammopathy of Undetermined Significance (MGUS), one year later he attended with erythematous macules on both arms, at this time the </span>electrophoresis<span> reported a polyclonal hypergammaglobulinemia. Immunologic panel reported ANA 1:2560, mitochondrial ANA 1:80, anti-double-stranded DNA IgG 15.3 and hipocomplementemia. We confirmed SLE and treatment was initiated. In our patient we ruled out MGUS, γHCD (γ-heavy-chain disease) and hypercalcemia related to HL-SLE. To our knowledge, the findings of monoclonal gammopathy and hypercalcemia as the onset of SLE have never been reported and the role of clinical laboratory was very important in the approach to establish a definitive diagnosis.</span></span></p></div>","PeriodicalId":101105,"journal":{"name":"Revista del Laboratorio Clínico","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.labcli.2018.07.005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91682719","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Alfonso J. Benítez-Estévez , Manuel Francisco Otero Santiago , Paloma Oliver Sáez , Javier Lirón Hernández , Fernando Rodríguez Cantalejo , Catalina Sánchez Mora , Imma Caballé Martín , José Luis Bedini Chesa , Ana M. García Raja , Antonio León Justel , Rafael Venta Obaya , Ana Isabel Quinteiro García , Montserrat Torra Puig
{"title":"Recomendaciones para la elaboración de un cuadro de mando integral para la gestión de pruebas en el lugar de asistencia del paciente (POCT). Recomendación (2017)","authors":"Alfonso J. Benítez-Estévez , Manuel Francisco Otero Santiago , Paloma Oliver Sáez , Javier Lirón Hernández , Fernando Rodríguez Cantalejo , Catalina Sánchez Mora , Imma Caballé Martín , José Luis Bedini Chesa , Ana M. García Raja , Antonio León Justel , Rafael Venta Obaya , Ana Isabel Quinteiro García , Montserrat Torra Puig","doi":"10.1016/j.labcli.2018.09.001","DOIUrl":"https://doi.org/10.1016/j.labcli.2018.09.001","url":null,"abstract":"<div><p>Technological development of <em>in vitro</em> diagnostics has led to a diversity of new tests for point-of-care testing (POCT) and at the same time provides quality in the process. Construction of a balanced scorecard is a useful tool for the success in the management of a cross-sectional, complex and interdisciplinary process, as well as to obtain reliable analytical results for immediately use with POCT systems. In constructing a balanced scorecard, four perspectives should be considered: Customer (patients, doctors), Financial (private or public investors), Operating procedures (systems, processes), and Professionals (organisational culture). The aim of this document is to establish the recommendations for the development of an adequate balanced scorecard to manage a point-of-care network in a healthcare system.</p></div>","PeriodicalId":101105,"journal":{"name":"Revista del Laboratorio Clínico","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.labcli.2018.09.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91637095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M.a José Alcaine Villarroya , Eva M. Barrenechea Iparraguirre , Elena Casals , Concepción González Rodríguez , Inmaculada Martín Navas , Hada Macher Manzano , M. Concepción Martínez Camarasa , Daniel Morell García , Helena Méndez Sol , Irene Rosas Allende , Elvira Tejedor Hernández , Belén Prieto García
{"title":"Utilidad de los marcadores bioquímicos de preeclampsia","authors":"M.a José Alcaine Villarroya , Eva M. Barrenechea Iparraguirre , Elena Casals , Concepción González Rodríguez , Inmaculada Martín Navas , Hada Macher Manzano , M. Concepción Martínez Camarasa , Daniel Morell García , Helena Méndez Sol , Irene Rosas Allende , Elvira Tejedor Hernández , Belén Prieto García","doi":"10.1016/j.labcli.2018.06.001","DOIUrl":"https://doi.org/10.1016/j.labcli.2018.06.001","url":null,"abstract":"<div><p>Pre-eclampsia (PE) is one of the leading causes of maternal and perinatal mortality in the world. In developed countries, studies point to a significant increase in the incidence of PE in the last decade, partly due to the increase in the prevalence in the general population of diseases that affect vascular function, such as diabetes. chronic hypertension, or kidney disease. An updated review of PE is presented in this article. The diagnostic criteria and the pathophysiology of the disease are described. The main objective of the document is to review the new biochemical markers that may be useful in clinical practice for the prediction and diagnosis of PE, as well as the different methods by which yey can be determined.</p></div>","PeriodicalId":101105,"journal":{"name":"Revista del Laboratorio Clínico","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.labcli.2018.06.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91636460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nazaret del Amo del Arco , Raquel Ramos Corral , Javier López Flores , Yessika M. Amezquita Orjuela , Alicia Roldán Pérez , Fernando Cava Valenciano
{"title":"Interferencia por ácido 2,4-diamino-N10-metilpteroico en la determinación de metotrexato tras la administración de glucarpidasa","authors":"Nazaret del Amo del Arco , Raquel Ramos Corral , Javier López Flores , Yessika M. Amezquita Orjuela , Alicia Roldán Pérez , Fernando Cava Valenciano","doi":"10.1016/j.labcli.2018.08.003","DOIUrl":"https://doi.org/10.1016/j.labcli.2018.08.003","url":null,"abstract":"<div><p>High-dose methotrexate (MTX) treatment involves close monitoring of drug level in order to confirm its proper elimination. One of the possible side effects of this therapy is renal failure, causing accumulation of the drug, and therefore is a mayor toxic effect. Glucarpidase (carboxypeptidase-G2 or CPDG2) is a recombinant enzyme used to reduce MTX serum levels in patients who develop acute renal failure during high-dose MTX treatment. The enzyme reduces MTX concentration by 95-99% within 15-30<!--> <!-->minutes after the dose. Glucarpidase cleaves MTX into glutamate and 2,4-diamino-N10-methylpteroic acid, a minor and non-active metabolite. Cross-reactivity of 2,4-diamino-N10-methylpteroic acid in immunological assays of MTX has been previously reported, and is said to cause an enormous overestimation in serum MTX analysis. However immunoassay is a widely used technique for MTX analysis, being the main method for its determination in most clinical laboratories.</p><p>An interference case report is presented and MTX analysis in serum samples by liquid chromatography coupled with Ultra-High Resolution Q-Time of Flight Mass Spectrometry (LC-UHR-QTOF) is described.</p></div>","PeriodicalId":101105,"journal":{"name":"Revista del Laboratorio Clínico","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91636461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cristina Ruiz, Jaume-Miquel March-Amengual, Gerard Reches, Salvador Ventura, J. M. Queraltó
{"title":"Una aplicación app para el diagnóstico de los micetismos","authors":"Cristina Ruiz, Jaume-Miquel March-Amengual, Gerard Reches, Salvador Ventura, J. M. Queraltó","doi":"10.1016/J.LABCLI.2019.01.005","DOIUrl":"https://doi.org/10.1016/J.LABCLI.2019.01.005","url":null,"abstract":"","PeriodicalId":101105,"journal":{"name":"Revista del Laboratorio Clínico","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79097661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}